BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12466487)

  • 1. Genetic recombination in wild-type poliovirus.
    Dahourou G; Guillot S; Le Gall O; Crainic R
    J Gen Virol; 2002 Dec; 83(Pt 12):3103-3110. PubMed ID: 12466487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polioviruses with natural recombinant genomes isolated from vaccine-associated paralytic poliomyelitis.
    Furione M; Guillot S; Otelea D; Balanant J; Candrea A; Crainic R
    Virology; 1993 Sep; 196(1):199-208. PubMed ID: 8102826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural genetic exchanges between vaccine and wild poliovirus strains in humans.
    Guillot S; Caro V; Cuervo N; Korotkova E; Combiescu M; Persu A; Aubert-Combiescu A; Delpeyroux F; Crainic R
    J Virol; 2000 Sep; 74(18):8434-43. PubMed ID: 10954543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic features of polioviruses isolated in Tunisia, 1991-2006.
    Haddad-Boubaker S; Ben Yahia A; Bahri O; Morel V; Balanant J; Delpeyroux F; Triki H
    J Clin Virol; 2008 Feb; 41(2):81-6. PubMed ID: 18023246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic variability of Poliovirus: typing of strains isolated in Madagascar by restriction fragment length polymorphism (RFLP) assay].
    Razafindratsimandresy R; Rakoto Andrianarivelo M; Rousset D
    Arch Inst Pasteur Madagascar; 2003; 69(1-2):27-32. PubMed ID: 15678812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.
    Cuervo NS; Guillot S; Romanenkova N; Combiescu M; Aubert-Combiescu A; Seghier M; Caro V; Crainic R; Delpeyroux F
    J Virol; 2001 Jul; 75(13):5740-51. PubMed ID: 11390576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
    Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
    Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 poliovirus recombinants isolated from vaccine-associated cases and from healthy contacts in Brazil.
    Friedrich F; Da-Silva EF; Schatzmayr HG
    Acta Virol; 1996 Feb; 40(1):27-33. PubMed ID: 8886095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sabin type 2 polioviruses with intertypic vaccine/vaccine recombinant genomes.
    Georgopoulou A; Markoulatos P
    Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):792-9. PubMed ID: 11783695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Molecular biological monitoring of the polioviruses circulation in Belarus].
    Beletskaia TS; Fel'dman EV; Samoĭlovich EO; Scheslenok EP; Kapustik LA
    Zh Mikrobiol Epidemiol Immunobiol; 2003; (1):29-36. PubMed ID: 12630350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare natural type 3/type 2 intertypic capsid recombinant vaccine-related poliovirus isolated from a case of acute flaccid paralysis in Brazil, 2015.
    Cassemiro KMSM; Burlandy FM; da Silva EE
    J Gen Virol; 2016 Jul; 97(7):1545-1550. PubMed ID: 27082658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Sabin-like Polioviruses from Sewage in Poland.
    Figas A; Wieczorek M; Żuk-Wasek A; Litwińska B
    Pol J Microbiol; 2018 Mar; 67(1):89-96. PubMed ID: 30015429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mutational pattern in 5'-NCR and VP1 regions of polioviruses for molecular diagnosis.
    Pliaka V; Dedepsidis E; Kyriakopoulou Z; Papadopoulou I; Levidiotou S; Markoulatos P
    Mol Cell Probes; 2007 Aug; 21(4):267-75. PubMed ID: 17336496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic analysis of recombinant sabin clinical isolates.
    Paximadi E; Karakasiliotis I; Mamuris Z; Stathopoulos C; Krikelis V; Markoulatos P
    Virus Genes; 2006 Apr; 32(2):203-10. PubMed ID: 16604453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site analysis of recombinant and mutant poliovirus isolates of Sabin origin from patients and from vaccinees.
    Karakasiliotis I; Markoulatos P; Katsorchis T
    Mol Cell Probes; 2004 Apr; 18(2):103-9. PubMed ID: 15051119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent isolation of poliovirus 3 strains with chimeric capsid protein Vp1 suggests a recombination hot-spot site in Vp1.
    Blomqvist S; Savolainen-Kopra C; Paananen A; El Bassioni L; El Maamoon Nasr EM; Firstova L; Zamiatina N; Kutateladze T; Roivainen M
    Virus Res; 2010 Aug; 151(2):246-51. PubMed ID: 20493912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China.
    Liu HM; Zheng DP; Zhang LB; Oberste MS; Kew OM; Pallansch MA
    J Virol; 2003 Oct; 77(20):10994-1005. PubMed ID: 14512548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild poliovirus circulation among healthy children immunized with oral polio vaccine in Antananarivo, Madagascar.
    Andrianarivelo MR; Rabarijaona L; Boisier P; Chezzi C; Zeller HG
    Trop Med Int Health; 1999 Jan; 4(1):50-7. PubMed ID: 10203174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective characterization of a vaccine-derived poliovirus type 1 isolate from sewage in Greece.
    Dedepsidis E; Kyriakopoulou Z; Pliaka V; Kottaridi C; Bolanaki E; Levidiotou-Stefanou S; Komiotis D; Markoulatos P
    Appl Environ Microbiol; 2007 Nov; 73(21):6697-704. PubMed ID: 17827314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.